Charlie Breese at Crowe UK

Charlie Breese

Director, Corporate Finance

I am a Director in Corporate Finance, working in the Lead Advisory team. I specialise in sell-side M&A, advising entrepreneurs, shareholders and management teams on mergers, acquisitions and capital raising in the lower mid-market, typically on deals of £5m–£100m.

In eight years in Corporate Finance I have advised on a wide range of transactions, including cross-border deals (particularly with buyers from the US and Europe), private equity exits, management buyouts and acquisitions.

I work mainly with owner-managed businesses, supporting them through the whole transaction, from early planning to completion. My earlier experience in buy-side Transaction Services means I understand how buyers assess a business, and I use that to prepare clients well and protect value on the way to exit. For a client, a successful transaction is often life-changing, and helping them shape their growth and exit plans is the most rewarding part of my job.

What I Do 

  • Sell-side M&A
  • Management Buyouts (MBOs)
  • Buy-side advisory
  • Capital raising

My Clients

  • Owner Managed Businesses
  • Entrepreneurs
  • SMEs
  • Private Equity
  • Transport and Logistics 
Insert Clear Filter Text
loading gif
lorry driving on road at dusk
Sale: Pentagon Freight Services
Crowe advised the shareholders of Pentagon Holdings Ltd, specialist freight forwarders in the oil and gas sector, on their sale to Jas Worldwide.
Pipette
Sale: Lexica
Crowe advised Guy’s and St Thomas’ NHS Trust, the shareholder of Lexica, a healthcare and life sciences consultancy practice, on its sale to WSP.
pipette
Acquisition: RApport Global Strategic Services
Crowe provided vendor due diligence to ELIQUENT Life Services, a regulatory consulting firm on its sale of RApport Global Strategic Services.
lorry driving on road at dusk
Sale: Pentagon Freight Services
Crowe advised the shareholders of Pentagon Holdings Ltd, specialist freight forwarders in the oil and gas sector, on their sale to Jas Worldwide.
Pipette
Sale: Lexica
Crowe advised Guy’s and St Thomas’ NHS Trust, the shareholder of Lexica, a healthcare and life sciences consultancy practice, on its sale to WSP.
pipette
Acquisition: RApport Global Strategic Services
Crowe provided vendor due diligence to ELIQUENT Life Services, a regulatory consulting firm on its sale of RApport Global Strategic Services.

Memberships


Awards


  • Deal of the Year Award (£40 million+)
  • South East Dealmakers (Insider Media)